Literature DB >> 4154851

The beta-blocking potency and cardioselectivity of tolamolol and its isomers in rodents.

K R Adam, J R Baird, R A Burges, J Linnell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4154851     DOI： 10.1016/0014-2999(74)90046-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  6 in total

1.  Isoprenaline antagonism of cardioselective beta-adrenergic receptor blocking agents on human and rat adipocytes.

Authors:  H H Harms; J Van der Meer
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

Review 2.  Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents.

Authors:  G Cocco; F Burkart; D Chu; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

3.  The effect on plasma prolactin, growth hormone and luteinising hormone concentrations of single oral doses or propranolol and tolamolol in normal man.

Authors:  C A Saxton; J K Faulkner; G V Groom
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  Clinical trial of a new beta-receptor blocking agent, tolamolol, in angina pectoris.

Authors:  I Nordenfelt; L Olsson; S Persson
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

5.  Bioavailability of tolamolol.

Authors:  J K Faulkner; D A Stopher; R Walden; W Singleton; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

Review 6.  The clinical pharmacology of beta adrenergic blocking drugs.

Authors:  D G McDevitt; R G Shanks; B N Prichard
Journal:  J R Coll Physicians Lond       Date:  1976-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.